53 related articles for article (PubMed ID: 16709454)
1. Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Nabuchi Y; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Aug; 16(15):4090-4. PubMed ID: 16709454
[TBL] [Abstract][Full Text] [Related]
2. Newly discovered orally active pure antiestrogens.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Yoneya T; Ohizumi I; Tsunenari T; Taniguchi K; Kaiho S; Nabuchi Y; Araya H; Kawata S; Morikawa K; Jo JC; Kwon HA; Lim HS; Kim HY
Bioorg Med Chem Lett; 2006 Sep; 16(18):4959-64. PubMed ID: 16806917
[TBL] [Abstract][Full Text] [Related]
3. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY
Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210
[TBL] [Abstract][Full Text] [Related]
4. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Characterization of molecular and structural determinants of selective estrogen receptor downregulators.
Fan M; Rickert EL; Chen L; Aftab SA; Nephew KP; Weatherman RV
Breast Cancer Res Treat; 2007 May; 103(1):37-44. PubMed ID: 17033922
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Tachibana K; Imaoka I; Yoshino H; Kato N; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem Lett; 2007 Oct; 17(20):5573-6. PubMed ID: 17804229
[TBL] [Abstract][Full Text] [Related]
8. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
Pennanen PT; Sarvilinna NS; Ylikomi TJ
Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ
Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors.
Mizutani T; Ishikawa S; Nagase T; Takahashi H; Fujimura T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
J Med Chem; 2009 Nov; 52(22):7289-300. PubMed ID: 19883081
[TBL] [Abstract][Full Text] [Related]
11. Clusterin: a potential target for improving response to antiestrogens.
Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1,3,3,4-tetrasubstituted pyrrolidine CCR5 receptor antagonists. Discovery of a potent and orally bioavailable anti-HIV agent.
Ma D; Yu S; Li B; Chen L; Chen R; Yu K; Zhang L; Chen Z; Zhong D; Gong Z; Wang R; Jiang H; Pei G
ChemMedChem; 2007 Feb; 2(2):187-93. PubMed ID: 17163560
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K
Bioorg Med Chem; 2007 Nov; 15(21):6692-704. PubMed ID: 17764960
[TBL] [Abstract][Full Text] [Related]
14. A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone.
Hirata M; Inada M; Matsumoto C; Takita M; Ogawa T; Endo Y; Miyaura C
Biochem Biophys Res Commun; 2009 Mar; 380(2):218-22. PubMed ID: 19159615
[TBL] [Abstract][Full Text] [Related]
15. Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
Kuwayama K; Inoue H; Kanamori T; Tsujikawa K; Miyaguchi H; Iwata Y; Miyauchi S; Kamo N; Kishi T
Forensic Sci Int; 2007 Aug; 170(2-3):183-8. PubMed ID: 17614227
[TBL] [Abstract][Full Text] [Related]
16. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of pure isoflavones and soymilk on estrogen receptor activity in mice.
Rando G; Ramachandran B; Rebecchi M; Ciana P; Maggi A
Toxicol Appl Pharmacol; 2009 Jun; 237(3):288-97. PubMed ID: 19361539
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel neuroprotective 1,2-dithiolane/chroman hybrids.
Koufaki M; Kiziridi C; Alexi X; Alexis MN
Bioorg Med Chem; 2009 Sep; 17(17):6432-41. PubMed ID: 19647438
[TBL] [Abstract][Full Text] [Related]
19. The antiestrogen [2-(4-benzylphenoxy)ethyl]diethylammonium chloride.
Hempel A; Camerman N; Dauter Z; Mastropaolo D; Camerman A
Acta Crystallogr C; 2000 Apr; 56 ( Pt 4)():455-6. PubMed ID: 10815207
[No Abstract] [Full Text] [Related]
20. Discovery of CYT997: a structurally novel orally active microtubule targeting agent.
Burns CJ; Harte MF; Bu X; Fantino E; Joffe M; Sikanyika H; Su S; Tranberg CE; Wilson N; Charman SA; Shackleford DM; Wilks AF
Bioorg Med Chem Lett; 2009 Aug; 19(16):4639-42. PubMed ID: 19616947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
